Matrixx Defends Zicam Adverse Event Nondisclosure In Supreme Court Brief
This article was originally published in The Pink Sheet Daily
Executive Summary
The company claims it did not disclose the AERs because they believed them to be an unreliable gauge that Zicam caused anosmia (lost sense of smell), not for any nefarious reason.